About

Substantial progress in the treatment of atherosclerotic complications – in particular in secondary prevention – has led to a significant reduction of recurrent cardiovascular events. This has been through the use of pharmacological strategies including lipid-lowering drugs such as statins, beta-blockers, angiotensin-converting ensyme inhibitors and angiotensin receptor blockers, along with the introduction of early percutaneous coronary intervention in acute coronary syndrome with consecutive application of dual antiplatelet therapy.

Articles

Atherosclerosis Plaque Imaging and Characterization Using Magnetic Resonance Imaging

The Adventitia - The New Frontier in Coronary Atherosclerosis Imaging

Citation:

Interventional Cardiology 2007;2(1):15-6

Statin-Fibrate Combination for the Treatment of Dyslipidaemia

Citation:

European Cardiology 2008;4(1):10–1

The Impact of Getting Patients with Both Hypertension and High Cholesterol to Target

Citation:

Asia-Pacific Cardiology 2008;2(1):33-4